Balboa Wealth Partners’s Gilead Sciences GILD Stock Holding History

Balboa Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$426K	Buy	3,057 +79	+3%	+$11.1K	0.07%	230
2025 Q4	$366K	Buy	+2,978	New	+$362K	0.06%	240
2025 Q2	–	Sell	-2,087	Closed	-$234K	–	389
2025 Q1	$234K	Buy	+2,087	New	+$215K	0.06%	238
2024 Q2	–	Sell	-3,514	Closed	-$257K	–	316
2024 Q1	$257K	Sell	3,514 -66	-2%	-$5.08K	0.08%	185
2023 Q4	$290K	Sell	3,580 -267	-7%	-$20.8K	0.1%	166
2023 Q3	$288K	Sell	3,847 -447	-10%	-$34.4K	0.11%	163
2023 Q2	$331K	Sell	4,294 -1,487	-26%	-$119K	0.12%	148
2023 Q1	$480K	Sell	5,781 -696	-11%	-$57.6K	0.18%	114
2022 Q4	$556K	Sell	6,477 -15,580	-71%	-$1.23M	0.25%	101
2022 Q3	$1.36M	Buy	+22,057	New	+$1.39M	0.6%	31

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Balboa Wealth Partners's GILD Position: Q1 2026 in Review

Balboa Wealth Partners increased its Gilead Sciences (GILD) stake by 2.7% in Q1 2026, buying an estimated $11.1K and bringing the position to 3,057 shares worth $426K. The position accounts for 0.07% of the portfolio, ranked #230.

Balboa Wealth Partners first reported a position in GILD in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.36M in Q3 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Balboa Wealth Partners held 3,057 shares of Gilead Sciences worth $426K as of Q1 2026.
Balboa Wealth Partners bought 79 Gilead Sciences shares in Q1 2026, an estimated $11.1K.
Gilead Sciences made up 0.07% of Balboa Wealth Partners's portfolio in Q1 2026, its #230 holding.
Balboa Wealth Partners first reported a position in Gilead Sciences in Q3 2022 and has held it in 10 quarters since.
Balboa Wealth Partners's Gilead Sciences position peaked at $1.36M in Q3 2022.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Balboa Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.